True 'market access' should involve coordinated approaches to patients and their healthcare providers
Dan Piggott, Ashfield
Advertisement
Articles by Dan Piggott, Ashfield
Advertisement
Latest Updated Articles
- Specialty pharmaceuticals demand integrated patient and prescriber approaches
Published: August 26th 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Confirms Cost Plus Drugs Partnership
2
Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending
3
Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network
4
The Hidden Costs of Prior Authorizations and Patient Loneliness
5
